Chemoinformaics analysis of (+)-8,9-Didehydro-Nootkatone
| Molecular Weight | 216.324 | nRot | 1 |
| Heavy Atom Molecular Weight | 196.164 | nRig | 13 |
| Exact Molecular Weight | 216.151 | nRing | 2 |
| Solubility: LogS | -2.85 | nHRing | 0 |
| Solubility: LogP | 3.051 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 36 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 39.1879 |
| nHD | 0 | BPOL | 20.9321 |
| QED | 0.651 |
| Synth | 4.324 |
| Natural Product Likeliness | 2.423 |
| NR-PPAR-gamma | 0.008 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.968 |
| Pgp-sub | 0.001 |
| HIA | 0.004 |
| CACO-2 | -4.721 |
| MDCK | 0.0000409 |
| BBB | 0.854 |
| PPB | 0.774527 |
| VDSS | 1.767 |
| FU | 0.290882 |
| CYP1A2-inh | 0.253 |
| CYP1A2-sub | 0.372 |
| CYP2c19-inh | 0.317 |
| CYP2c19-sub | 0.89 |
| CYP2c9-inh | 0.309 |
| CYP2c9-sub | 0.145 |
| CYP2d6-inh | 0.036 |
| CYP2d6-sub | 0.244 |
| CYP3a4-inh | 0.067 |
| CYP3a4-sub | 0.643 |
| CL | 9.247 |
| T12 | 0.737 |
| hERG | 0.031 |
| Ames | 0.209 |
| ROA | 0.155 |
| SkinSen | 0.962 |
| Carcinogencity | 0.615 |
| EI | 0.962 |
| Respiratory | 0.966 |
| NR-Aromatase | 0.133 |
| Antiviral | Yes |
| Prediction | 0.788266 |